EVEREST - Trademark Details
Status: 605 - Abandoned - After Publication
Serial Number
88584518
Word Mark
EVEREST
Status
605 - Abandoned - After Publication
Status Date
2020-11-30
Filing Date
2019-08-19
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-09-22
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
GULIANO, ROBERT N
Statements
Goods and Services
Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs
Goods and Services
Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal diseases, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory diseases, metabolic diseases, dermatology, and gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, and gastrointestinal or women's health; pharmaceutical preparations for health care, namely, for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, and gastrointestinal or women's health; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for oncology/hematology, immunology, cardiology, renal diseases, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory diseases, metabolic diseases, dermatology, and gastrointestinal or women's health
Goods and Services
Pharmaceutical research; research and development of pharmaceuticals; drug development, namely, pharmaceutical drug development services; drug discovery services; pharmaceutical drug development services; research and development of vaccines and medicines, excluding any use in connection with for-fee services typically provided by clinical research organizations
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
8 - Abandoned
Class Status Date
2020-11-30
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
8 - Abandoned
Class Status Date
2020-11-30
Primary Code
005
Correspondences
Name
David Devernoe
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2019-08-22 | NEW APPLICATION ENTERED IN TRAM |
2019-09-04 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2019-10-16 | LETTER OF PROTEST ACCEPTED |
2019-11-18 | ASSIGNED TO EXAMINER |
2019-11-20 | NON-FINAL ACTION WRITTEN |
2019-11-20 | NON-FINAL ACTION E-MAILED |
2019-11-20 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-04-15 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-04-15 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-04-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-05-20 | ASSIGNED TO EXAMINER |
2020-06-04 | NON-FINAL ACTION WRITTEN |
2020-06-04 | NON-FINAL ACTION E-MAILED |
2020-06-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-06-24 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-07-06 | ASSIGNED TO LIE |
2020-07-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-07-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-08-03 | NON-FINAL ACTION WRITTEN |
2020-08-03 | NON-FINAL ACTION E-MAILED |
2020-08-03 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2020-08-17 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2020-08-17 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2020-08-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2020-08-18 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2020-09-02 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2020-09-22 | PUBLISHED FOR OPPOSITION |
2020-09-22 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2020-09-22 | EXTENSION OF TIME TO OPPOSE RECEIVED |
2020-11-24 | TEAS EXPRESS ABANDONMENT RECEIVED |
2020-11-30 | ABANDONMENT - AFTER PUBLICATION |
2020-11-30 | ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION |